Company intelligence / Profile preview

Orient Bio

Seongnam-si, Gyeonggi-do, South Korea

Ownership: Private
Employees: ~125
Development stage: Other

Overview

Orient Bio is a leading South Korean biotechnology company specializing in the production and supply of laboratory animals and research equipment for the pharmaceutical, biotech, and healthcare sectors. It supports biomedical research, diagnostics, and various therapeutic solution development through expertise in genetic engineering and molecular biology. There is no specific information on clinical results or programs in drug development.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Orient Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orient Bio.

Explore the full profile